ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Net Cash Flow of -$405903.0 for Q1 2026, up 65.15% year-over-year from -$245783.2 in Q1 2025, and down 1181.58% quarter-over-quarter from -$31672.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Net Cash Flow for 11 consecutive years, with -$405903.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 65.15% year-over-year to -$405903.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 283.67% YoY), while the FY2025 annual figure was -$2.5 million, down 723.68% from the prior year.
- Net Cash Flow declined to -$405903.0 in Q1 2026 per NDRA's latest filing, from -$31672.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $5.3 million in Q2 2024 and bottomed at -$3.3 million in Q3 2022.
- Historically, Net Cash Flow has averaged -$535592.4 across 5 years, with a median of -$1.2 million in 2025.
- Annual changes were most pronounced in 2022 — Net Cash Flow surged 248.27% — and 2024, when it tumbled 202.76%.
- ENDRA Life Sciences' Net Cash Flow stood at -$3.1 million in 2022, then jumped by 83.99% to -$500629.0 in 2023, then sank by 202.76% to -$1.5 million in 2024, then jumped by 97.91% to -$31672.0 in 2025, then plunged by 1181.58% to -$405903.0 in 2026.
- Business Quant data shows NDRA's Net Cash Flow at -$405903.0 in Q1 2026, -$31672.0 in Q4 2025, and -$1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 718.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.34 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3.57 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 56.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -37.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -3.52 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -50.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -9.27 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -840.60 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 5.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.18 Mn |
| Jun 30, 2026 | 5.18 Mn |
| Mar 31, 2026 | -405,903.00 |
| Mar 31, 2026 | -405,903.00 |
| Dec 31, 2025 | -31,672.00 |
| Dec 31, 2025 | -31,672.00 |
| Sep 30, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -256,300.00 |
| Jun 30, 2025 | -256,300.00 |
| Mar 31, 2025 | -1.16 Mn |
| Mar 31, 2025 | -1.16 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Mar 31, 2024 | -1.70 Mn |